Jane Street’s Allena Pharmaceuticals ALNA Stock Holding History

Jane Street’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,558	Closed	-$3K	–	11414
2022 Q1	$3K	Sell	12,558 -688	-5%	-$285	﹤0.01%	10161
2021 Q4	$8K	Sell	13,246 -40,718	-75%	-$31.8K	﹤0.01%	9930
2021 Q3	$49K	Buy	+53,964	New	+$52.8K	﹤0.01%	9554
2020 Q4	–	Sell	-15,011	Closed	-$22K	–	8375
2020 Q3	$22K	Buy	+15,011	New	+$21.1K	﹤0.01%	7031
2019 Q3	–	Sell	-28,570	Closed	-$116K	–	5995
2019 Q2	$116K	Buy	+28,570	New	+$156K	﹤0.01%	4824

Other funds holding ALNA

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Jane Street's ALNA Position: Q2 2022 in Review

Jane Street sold out of Allena Pharmaceuticals (ALNA) in Q2 2022, closing a stake of 12,558 shares — an estimated $3K sold.

Jane Street first reported a position in ALNA in Q2 2019 and held it in 5 quarters. The position peaked at $116K in Q2 2019. 25 funds tracked by Wall St. Rank hold ALNA as of Q2 2022.

Jane Street reported no remaining Allena Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Jane Street sold 12,558 Allena Pharmaceuticals shares in Q2 2022, an estimated $3K.
Jane Street first reported a position in Allena Pharmaceuticals in Q2 2019 and held it in 5 quarters.
Jane Street's Allena Pharmaceuticals position peaked at $116K in Q2 2019.
25 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2022.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.